Document is current
Any future updates will be listed below
-
Authors
Kilic, B. Ülgen https://orcid.org/0000-0002-4096-8417
Jubeir, Jenna https://orcid.org/0009-0009-2338-9593
Balchandani, Priti
Murrough, James W. https://orcid.org/0000-0001-6286-1242
Morris, Laurel S. https://orcid.org/0000-0002-5862-6650
Jacob, Yael https://orcid.org/0000-0003-3278-9264
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 MH109544)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K01MH12043)
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 3 April 2026
First Online: 23 April 2026
Competing interests
: Dr. Murrough has provided paid consultation services for Autobahn Therapeutics, Inc., Biohaven Pharmaceuticals, Inc., Cliniclabs, Inc., Clexio Biosciences, Ltd., Compass Pathfinder, Plc., Frontier Pharma, LLC, HMP Collective, Janssen Pharmaceuticals, LivaNova, Plc., Merck & Co., Inc., Otsuka Pharmaceutical, Ltd, WCG Clinical, Inc., and Xenon Pharmaceuticals, Inc. Dr. Priti Balchandani is a named inventor on patents relating to magnetic resonance imaging (MRI) and RF pulse design. This intellectual property has been licensed to GE Healthcare, Siemens AG, and Philips international. Dr. Balchandani received one-time royalty payments for this intellectual property. The remaining authors declare no competing interests.
